ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
Learn more about:
Related Clinical Trial
Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome
Prevalence of Acute Hepatic Porphyria
ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)
A Study to Investigate the Interaction Between Givosiran and a 5-probe Drug Cocktail in Patients With Acute Intermittent Porphyria (AIP)
Acute Porphyria Biomarkers for Disease Activity
Panhematin for Prevention of Acute Attacks of Porphyria
Clinical Diagnosis of Acute Porphyria
INSIGHT-AHP: A Study to Characterize the Prevalence of Acute Hepatic Porphyria (AHP) in Patients With Clinical Presentation and History Consistent With AHP
ENVISION: A Study to Evaluate the Efficacy and Safety of Givosiran (ALN-AS1) in Patients With Acute Hepatic Porphyrias (AHP)
EXPLORE: A Natural History Study of Acute Hepatic Porphyria (AHP)
Expanded Access Protocol of Givosiran for Patients With Acute Hepatic Porphyria